PharmaNutra SpA (IT:PHN) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
PharmaNutra S.p.A. has signed a distribution agreement with Sigma Lifesciences to market its SiderAL® and Ultramag® products in Canada, expanding its presence in North America. The products, which feature the patented Sucrosomial® Technology, are set to launch in the second quarter of 2025. This strategic move aims to capitalize on the significant market potential in Canada.
For further insights into IT:PHN stock, check out TipRanks’ Stock Analysis page.